Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

Drug firm Divi's Laboratories on Monday said its profit after tax (PAT) increased 65 per cent to Rs 589 crore for the ...

The company clocked a 4% increase in net profit, which stood at ₹4.53 crore for Q2 of the ongoing financial year. This ...

Booz Allen Hamilton (BAH) reported Q3 EPS of $1.55, beating estimates of $1.51. Sales of $2.92B and backlog growth of 14.8% ...

In the corresponding quarter of the previous fiscal, Alembic Pharmaceuticals posted a net profit of ₹180.4 crore. The company ...

Sportback makes its spy shot debut ahead of this year’s reveal and more than a year after we first spotted the regular Q3 ...